← all works
RETRACTED: Loss of Heterozygosity and DNA Methylation Affect Germline Fibroblast Growth Factor Receptor 4 Polymorphism to Direct Allelic Selection in Breast Cancer
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Post-publication record
- Nature
- Retraction
- Reason
- Falsification/Fabrication of Data;Falsification/Fabrication of Image;Investigation by Company/Institution;Investigation by Journal/Publisher;
- Date
- 7/26/2015 0:00
- Flagged by OpenAlex?
- Yes
Source: Retraction Watch, joined by DOI. OpenAlex records retraction as is_retracted, a boolean over a state space with at least four values, so it cannot express an expression of concern, a correction or a reinstatement — it reports them as false, which reads as “fine”.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- American Journal Of Pathology
- Topic
- Fibroblast Growth Factor Research
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- University Health NetworkUniversity of TorontoOntario Institute for Cancer Research
- Funders
- Canadian Institutes of Health Research
- Keywords
- Loss of heterozygosityGermlineAlleleBreast cancerBiologyGeneticsDNA methylationCancer researchCancerGene
- Has abstract in OpenAlex
- no